Potential Buyers Looking at Drugmaker Roivant

The video discusses a company's shares reopening after a halt, initially rising by 10%. A Bloomberg report suggests that large pharmaceutical companies are interested in a treatment for inflammatory bowel disease, potentially leading to a deal worth over $7 billion. The company's market cap is around $8 billion, making this a significant potential deal. The company has declined to comment on the situation.

What treatment is the company developing that has attracted interest from large pharma companies?

According to Bloomberg, how much could the potential deal be worth?

What is the current status of the company's shares after reopening?

What is the market cap of the company mentioned in the text?

What has the New York based company representatives declined to do regarding the situation?